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(57) ABSTRACT 
A breath condensate collection apparatus comprising a cen-
tral chamber, a breath input assembly, a plunger assembly 
and a breath condensate collection port. The central chamber 
has inner and outer side walls with a coolant material sealed 
in between. The breath input assembly is disposed on the 
side of the central chamber in fluid communication with the 
chamber interior. The plunger assembly has a piston, slid-
ably disposed in the chamber, and a handle extending from 
a first end of the chamber. The collection port is disposed at 
the second end of the central chamber in fluid communica-
tion with the interior of the chamber. Obstructive structures 
may be arranged in the chamber interior for increasing the 
surface area on which condensate may form. The apparatus 
may also include an outlet assembly that may be removed 
and replaced with a sampling well into which the condensate 
may be washed with a buffer solution. 
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DISPOSABLE HAND-HELD DEVICE FOR 
COLLECTION OF EXHALED BREATH 
CONDENSATE 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
[0001] This application is entitled to the benefit of, and 
claims priority to, provisional U.S. Patent Application Serial 
No. 60/434,916 filed Dec. 20, 2002 and entitled "DISPOS-
ABLE HAND-HELD DEVICE FOR COLLECTION OF 
EXHALED BREATH CONDENSATE FOR ASSAY OF 
BIOMARKERS FOR THE DETECTION AND PROGNO-
SIS OF LUNG ISCHEMIA," and provisional U.S. Patent 
Application Serial No. 60/447,581 filed Feb. 14, 2003 and 
entitled "DEVICE AND METHOD FOR COLLECTION 
OF EXHALED ALVEOLAR BREATH CONDENSATE," 
the entirety of each of which is incorporated herein by 
reference. 
BACKGROUND OF THE PRESENT 
INVENTION 
[0002] 1. Field of the Present Invention 
[0003] The present invention relates to the collection of 
breath condensate medical testing and diagnosis, and, in 
particular, to a double-walled chamber having a coolant 
material embedded between the inner and outer walls, a 
side-mounted breath input assembly, an outlet from which 
condensate may be collected, and a plunger for expressing 
the condensate through the outlet. The collected sample may 
then be tested for biomarkers indicating the presence and 
severity of lung ischemia and associated pulmonary vaso-
constriction. 
[0004] 2. Background 
[0005] Approximately 6% of exhaled breath is water 
vapor and water droplets. One source of water in breath is 
from the fluids that line the alveoli of the lung. In other 
words, the water vapor exhaled from the breath equilibrates 
with fluid in the bronchi and alveoli, and therefore breath 
condensate collection provides a noninvasive means of 
sampling these fluids. 
[0006] Exhaled breath condensate contains water soluble 
and water insoluble molecules, including dissolved gases, 
organic solutes, ions and proteins. Breath condensate 
samples from patients with certain diseases have been 
shown to contain elevated content of inflammatory mol-
ecules. For example, previous work has demonstrated that 
smoking, asthma and cystic fibrosis increase the presence of 
prostaglandin derivatives, thromboxane, leukotrienes and 
cytokines. (SA Kharitonov and P J Barnes, Exhaled markers 
of pulmonary disease,AmJ Respir Crit Care Med 163:1693-
1722, 2001.) Until recently, though, little work has been 
done to identify biomarkers in exhaled breath water vapor 
that may be able to assist in determining the presence and 
severity of lung ischemia. 
[0007] However, recent research indicates that it may be 
possible to detect lung ischemia by performing a battery of 
tests on relatively small breath condensate samples. A pro-
posed battery of tests for lung ischemia may include fibrin-
opeptides, thromboxane B2, platelet activating factor, leu-
kotrienes C, D and E, carbon monoxide-to-nitric oxide ratio 
and chemokine and other proteins. Measurement of fibrin-
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opeptides in breath condensate is believed to have the 
potential to allow more localized measurement of the pres-
ence of clot in the lung vasulature. It is publicly known that 
thrombin cleaves fibrinogen A peptide from fibrinogen as a 
prerequisite to fibrin gelation. Owing to its small size, it is 
hypothesized that fibrinopeptides will traverse the alveolar 
membrane, and equilibrate in alveolar fluid, and thus will be 
found in exhaled condensate. 
[0008] It is also believed that pulmonary vascular con-
striction may be detected by measuring PGF2 w thrombox-
ane B2 , PAF, leukotrienes C, D, and E, and the ratio of CO 
to NO in condensate, thus providing a basis for initiating 
pulmonary vasodilator therapy or COXl,2 inhibition. Our 
laboratory has used an experimental pulmonary vascular 
occlusion (PYO), induced by venous infusion of polystyrene 
microspheres in a rat, to determine three major findings 
related to breath condensate analysis. We and others have 
found increased content of PGF2 w thromboxane B2 , platelet 
activating factor (PAF) and vasoconstrictive leukotrienes C, 
D, and E in the lung washings in our rat model. (Nakos, Am 
J Resp Crit Care Med 1998, 158:1504) The magnitude of the 
concentration of these vasoconstrictive agents correlated 
with the severity of hypoxemia and pulmonary hyperten-
sion. We also have found extremely elevated expression of 
the gene encoding heme oxygenase-1 but the nearly com-
plete absence of expression of the gene encoding for the 
inducible enzyme, nitric oxide synthase. Heme oxygenase 
produces carbon monoxide (CO) from heme substrate 
whereas nitric oxide synthase produces nitric oxide (NO). 
Both are vasodilator substances. In rats subjected to PYO, 
we have also found early increases in lung gene expression 
of cytokine induced neutrophil attractant 1 and 2 (CINC 1 & 
2), and monocyte/macrophage chemoattractant protein 
(MCP) 1 and 2, and monocyte/macrophage inflammatory 
proteins (MIP) la and l~ with concomitant increases in 
each protein in the washings from the lung airways and 
alveoli obtained as soon as 2 hours after induction of PE, and 
lasting up to 18 hours after PE induction. The chemoattrac-
tant molecules can cause the migration of leukocytes into the 
affected area, and through this mechanism, can potentiate 
injury during therapeutic reperfusion. 
[0009] Further, the presence of certain chemokines in 
exhaled condensate is believed to predispose reperfusion 
injury. The chemokines discovered in rats included CINC 1, 
CINC 2, MIP la, MIP l~, and MCP 1 and 2. The human 
homologues that will be tested in our device will include 
CXCLl, CXCL 2 and CXCL 3; CCL 2, CCL 3, CCL 4 and 
CCL8, using nomenclature outlined by Zlotnick and Yoshie, 
Immunity, 2000, 12:121-127. Chemokines have been found 
with an inflammatory model of pulmonary hypertension. 
(Kimura, Lab Invest 1998 78:571-81; Ikeda, Am J Physiol 
Heart Circ Physiol, 2002, 283(5):H2021-8). Unlike the 
in-vivo PYO model, which causes primarily obstructed 
blood flow, the model in the latter study incites inflammation 
and remodeling, which over weeks leads to vascular occlu-
sion. Likewise, investigators have also found increased 
chemokine expression in lungs subjected to hilar ligation or 
clamping, which interrupts both perfusion and ventilation. 
The latter model differs significantly from in-vivo PYO 
because alveolar ventilation continues with in-vivo PYO. 
Thus the ischemic insult differs with in-vivo PYO versus 
hilar ligation. 
US 2004/0138577 Al 
[0010] Attempts have been made to analyze exhaled 
breath, including breath condensate, or otherwise measure 
certain components of exhaled breath. For example, U.S. 
Pat. Nos. 6,419,634 and 6,033,368 to Gaston IV et al. 
disclose a disposable device with a coolant coaxially sur-
rounding a tube in order to cool exhaled breath sufficiently 
to cause condensation on the walls of the inner tube. 
Unfortunately, the device is designed for the measurement of 
nitrogen oxides and is not intended to facilitate protein or 
eicosinoid determinations on breath condensate. As a result, 
it suffers from a number of drawbacks. First, the Gaston 
device is mounted directly on the analyzer, and thus is too 
large and too cumbersome to use at the bedside for collec-
tion of small volumes of condensate in emergency depart-
ment or other ambulatory patients. The Gaston device also 
suffers from inefficient sample collection inasmuch as the 
sample must be aggregated in one chamber and then trans-
ferred by the combined actions of droplet accretion and 
gravity to a separate second chamber for analysis. Perhaps 
worse, the Gaston device is incapable of use separate from 
the analyzer, in that the apparatus collects condensate in a 
chamber specifically designed for spectrophotometric analy-
sis for nitrogen oxides, and thus has no port or other 
accessible reservoir from which condensate may be aspi-
rated, aliquotted or otherwise withdrawn and subsequently 
transferred to a separate assay well to measure the compo-
nents of the panel described above. 
[0011] Further, although Gaston mentions the use of a 
device similar to a syringe plunger in expressing condensed 
fluid down its inner tube, Gaston fails to solve the problem 
of how to integrate such a plunger with the inlet tube. Also, 
even the inclusion of a plunger to express fluid down the 
inner tube of the Gaston device would still fail to solve the 
additional problem described previously; that is, Gaston still 
discloses no simple way to remove the fluid for removing 
and transferring the collected fluid for testing outside of the 
analyzing chamber. Finally, the Gaston coolant is not cali-
brated to permit condensation of a calibrated amount of 
condensate from a limited number of breaths. Instead, the 
Gaston device requires a lengthy period of sustained breath-
ing in order to collect a sufficient quantity of condensate, a 
problem that is exacerbated by the absence of a plunger to 
more efficiently remove condensate from the device. This is 
due in large part to the considerable quantities of condensate 
that are necessary in Gaston for the intended type of testing 
to be performed thereon. As discussed previously, a major 
purpose of the present application is to collect relatively the 
small quantities of condensate necessary to perform the 
types of tests described above. Because such testing was not 
anticipated by Gaston, the Gaston device was not developed 
to permit such testing. Thus, a need exists for a fast and 
convenient apparatus and method for collecting small 
amounts of breath condensate in a manner that permits 
aliquotting as desired for the performance of tests such as the 
ones described above. 
SUMMARY OF THE PRESENT INVENTION 
[0012] It is hypothesized that the ability to measure par-
ticular biomarkers in exhaled breath water vapor, such as the 
ones described above, can assist in determining the presence 
and severity of lung ischemia. Lung ischemia can be caused 
by multiple processes, including thromboembolism, sickle 
cell disease, fat and air embolism. The ability to collect 
breath condensate rapidly and easily with a point-of-care 
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device would improve the clinical utility of breath-based 
diagnosis for this purpose, particularly in the emergency 
department or clinic setting. The devices described herein 
are designed to allow a patient to breath into a handheld 
disposable chamber to facilitate the collection of approxi-
mately 100-1000 microliters of aerosolized and vaporized 
water and solutes, which can then be analyzed for the 
presence of specific proteins and other organic compounds, 
using enzyme-linked immunoassay, and the measurement of 
the proportion of carbon monoxide relative to nitric oxide 
using laser spectrophotometry. 
[0013] It is an object of the present invention to provide a 
method of allowing cold-trapping of exhaled water vapor in 
a portable device. 
[0014] It is another object of the present invention to 
provide a mechanism to permit use of frozen water of a 
known volume such that the ice melts after a known number 
of exhalations to permit collection of condensed exhaled 
water aerosol and vapor. 
[0015] It is yet another object of the present invention to 
provide a breath condensate collection device having a 
series of valves to prevent contamination by water vapor and 
ambient air. 
[0016] It is still another object of the present invention to 
provide a breath condensate collection device using a 
plunger-type mechanism to express collected condensate 
into a small reservoir to facilitate fluid collection. 
[0017] It is yet another object of the present invention to 
construct a breath condensate collection device using mate-
rials to allow minimal cost of the device such that it is a 
disposable unit to minimize cost of the device. 
[0018] It is still another object of the present invention to 
provide a method for the collection and aliquotting of a 
breath condensate sample in an expeditious fashion to 
facilitate testing for vasoconstrictor molecules, the measure-
ment of the CO-to-NO ratio and the measurement of 
chemokine proteins. 
[0019] The present invention comprises apparatuses and 
methods for non-invasively collecting breath condensate 
from a patient for testing purposes. Broadly defined, the 
present invention according to one aspect is a breath con-
densate collection apparatus, including: a central chamber 
having double side walls and first and second opposing ends, 
where the double side walls include an inner side wall and 
an outer side wall in spaced relationship to one another; a 
coolant material sealed between the inner and outer side 
walls for cooling at least the inner walls of the central 
chamber; a breath input assembly disposed on the outside of 
the outer side wall of the central chamber and penetrating 
both the inner and outer side walls such that the interior of 
the breath input assembly is in fluid communication with the 
interior of the central chamber; a plunger assembly having 
a piston and a handle, the piston being slidably disposed in 
the interior of the central chamber in snug contact with the 
inner side wall and the handle extending from the first end 
of the central chamber so as to permit the piston to be moved 
within the central chamber; and a breath condensate collec-
tion port, disposed at the second end of the central chamber, 
in fluid communication with the interior of the central 
chamber. 
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[0020] In features of this aspect, the plunger assembly is 
adjustable between a fully retracted position and a fully 
depressed position, and when the plunger is in its fully 
retracted position, the fluid connection between the breath 
input assembly and the central chamber lies in between the 
piston and the second end of the central chamber; the 
location of the breath input assembly on the outside of the 
outer side wall of the central chamber is adjacent the first 
end of the central chamber; the central chamber includes an 
end wall at the second end thereof, and the breath conden-
sate collection port is disposed in the end wall of the central 
chamber; the piston includes a surface facing toward the 
second end of the central chamber, a protrusion is disposed 
on the surface of the piston, and the protrusion is adapted to 
fit into the breath condensate collection port when the 
plunger assembly is fully depressed into the central cham-
ber; the breath condensate collection port and the protrusion 
are each semi-conical in shape; one or more grooves are 
disposed in the sides of the protrusion to facilitate guiding 
breath condensate toward the breath condensate collection 
port; one or more internal passages are disposed in the 
interior of the protrusion to facilitate guiding breath con-
densate toward the breath condensate collection port; the 
breath condensate collection port is disposed on the outside 
of the outer side wall of the central chamber adjacent the 
second end thereof, the breath condensate collection port is 
disposed on the bottom of the central chamber, and the 
breath condensate collection apparatus also includes an 
outlet and an outlet valve disposed on the top of the outer 
side wall of the central chamber adjacent the second end 
thereof; the breath condensate collection apparatus also 
includes a cap for temporarily sealing the breath condensate 
collection port; the breath condensate collection apparatus 
defines a main axis, the breath input assembly has a mouth-
piece and a tube structure connecting the mouthpiece to the 
side of the central chamber, and the mouthpiece is generally 
oriented in parallel to the main axis of the breath condensate 
collection apparatus; and the breath condensate collection 
apparatus also includes at least one clip, mounted at the first 
end of the central chamber, for locking the handle of the 
plunger assembly in a fully depressed position to facilitate 
transport or handling of the breath condensate collection 
apparatus until breath condensate collected therein may be 
removed. 
[0021] The present invention, according to another aspect 
of the present invention, is a method of collecting breath 
condensate, including: providing a central chamber having 
double side walls, first and second opposing ends, a coolant 
material sealed between the inner and outer side walls for 
cooling at least the inner walls of the central chamber, and 
a breath condensate collection port disposed at the second 
end of the central chamber; lowering the temperature of the 
coolant material to chill at least the inner walls of the central 
chamber; receiving, in the interior of the central chamber, 
exhaled breath from a patient, delivered through the inner 
and outer side walls via a breath input assembly disposed on 
the outside of the outer side wall of the central chamber; 
condensing portions of the exhaled breath on the inner 
surfaces of the inner walls of the central chamber; express-
ing condensate, produced during the condensing step, from 
the central chamber by depressing a plunger assembly 
through the central chamber, thereby forcing the condensate 
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into the breath condensate collection port; and aspirating the 
expressed condensate from the breath condensate collection 
port for analysis thereof. 
[0022] In features of this aspect, the aspirating step 
includes aspirating the expressed condensate into a pipette, 
and the method also includes transferring the condensate 
from the pipette to a separate assay well for analysis thereof; 
the providing step includes providing a central chamber 
having an outlet and outlet valve disposed on the top of the 
outer side wall of the central chamber adjacent the second 
end thereof and having the breath condensate collection port 
disposed on the bottom of the central chamber, and the 
method also includes temporarily sealing the breath conden-
sate collection port during the receiving and condensing 
steps; and the step of providing includes providing a central 
chamber having at least one clip mounted at the first end of 
the central chamber, and the method also includes, after 
expressing the condensate by depressing the plunger assem-
bly, a step of locking, via the at least one clip, the handle of 
the plunger assembly in a fully depressed position to facili-
tate transport or handling of the breath condensate collection 
apparatus until aspirating the expressed condensate. 
[0023] The present invention, according to another aspect 
of the present invention, is a breath condensate collection 
apparatus, including: a central chamber having double side 
walls including an inner side wall and an outer side wall in 
spaced relationship to one another; a coolant material sealed 
between the inner and outer side walls for cooling at least the 
inner walls of the central chamber; a breath input assembly, 
the interior of which is in fluid communication with the 
interior of the central chamber; one or more obstructive 
structures arranged in the interior of the central chamber for 
increasing the surface area on which condensate may form; 
and a breath condensate collection port in fluid communi-
cation with the interior of the central chamber. 
[0024] In features of this aspect, the obstructive structures 
include grid-like structures; the obstructive structures 
include discrete geometric structures; the discrete geometric 
structures include spherical objects; the discrete geometric 
structures are formed from metal; the discrete geometric 
structures are formed from glass; the obstructive structures 
are fixed in place within the interior of the central chamber; 
the obstructive structures are free-floating within the interior 
of the central chamber; and movement of the obstructive 
structures is restricted to a particular portion of the central 
chamber. 
[0025] The present invention, according to another aspect 
of the present invention, is a method of collecting breath 
condensate, including: providing a double-walled central 
chamber having one or more obstructive structures arranged 
in the interior thereof and a coolant material sealed between 
the inner and outer side walls for cooling at least the inner 
walls of the central chamber; lowering the temperature of 
the coolant material to chill at least the inner walls of the 
central chamber and the obstructive structures; receiving, in 
the interior of the central chamber, exhaled breath from a 
patient; condensing portions of the exhaled breath on the 
inner surfaces of the inner walls of the central chamber and 
on the obstructive structures; and removing condensate, 
produced during the condensing step, from the central 
chamber. 
[0026] In features of this aspect, the removing step 
includes washing the condensate from the obstructive struc-
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tures; the washing step includes adding an amount of liquid 
to the central chamber, and the amount is selected to 
correspond to the amount of condensate present in the 
central chamber; the washing step includes adding an 
amount of liquid to the central chamber, and the amount is 
selected to correspond to the amount of condensate likely to 
be present in the central chamber after the patient exhales 
into the central chamber for a predetermined period of time; 
the washing step includes adding an amount of liquid to the 
central chamber, and the amount is selected to correspond to 
the amount of condensate likely to be present in the central 
chamber after the patient completes a predetermined number 
of exhalations into the central chamber; and the method 
further includes removing the obstructive structures from the 
central chamber before carrying out the washing step. 
[0027] The present invention, according to another aspect 
of the present invention, is a method of collecting breath 
condensate, including: providing a double-walled central 
chamber having a removable outlet assembly and a coolant 
material sealed between the inner and outer side walls for 
cooling at least the inner walls of the central chamber; 
lowering the temperature of the coolant material to chill at 
least the inner walls of the central chamber; receiving, in the 
interior of the central chamber, exhaled breath from a 
patient; condensing portions of the exhaled breath on the 
inner surfaces of the inner walls of the central chamber; 
removing the outlet assembly and replacing it with a sam-
pling well; and moving condensate, produced during the 
condensing step, from the central chamber to the sampling 
well. 
[0028] In features of this aspect, the step of moving 
condensate includes washing condensate from the central 
chamber into the sampling well with a known liquid; the step 
of washing condensate includes introducing a predetermined 
quantity of the known liquid into the central chamber, 
mixing the predetermined quantity of the known liquid with 
the condensate, and draining the known liquid and the 
condensate from the central chamber into the sampling well; 
the step of removing the outlet assembly includes creating 
an opening into the central chamber, and the step of intro-
ducing includes introducing the known liquid through the 
opening; the method further includes storing the known 
liquid in the sampling well before replacing the outlet 
assembly with the sampling well; and the known liquid is a 
buffer solution. 
[0029] The present invention, according to another aspect 
of the present invention, is a method of collecting breath 
condensate, including: providing a double-walled central 
chamber having one or more obstructive structures arranged 
in the interior thereof and a coolant material sealed between 
the inner and outer side walls for cooling at least the inner 
walls of the central chamber; calibrating the walls and 
coolant material of the double-walled central chamber such 
that, when beginning at a predetermined temperature, a 
chosen number of breaths, received from a typical patient, 
creates a sufficient amount of breath condensate to be 
collected on the inner surfaces of the inner walls of the 
central chamber; lowering the temperature of the coolant 
material to the predetermined temperature to chill at least the 
inner walls of the central chamber; receiving, in the interior 
of the central chamber, a plurality of exhalations from a 
particular patient, where the number of exhalations is within 
a predetermined range established on the basis of the chosen 
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number of breaths; condensing portions of the exhalations, 
received from the patient, on the inner surfaces of the inner 
walls of the central chamber; and removing condensate, 
produced during the condensing step, from the central 
chamber. 
[0030] In features of this aspect, the predetermined range 
is 10 to 25 breaths, inclusive; the predetermined temperature 
is the temperature of a standard freezer; and the predeter-
mined temperature is 0° F. 
BRIEF DESCRIPTION OF THE DRAWINGS 
[0031] Further features, embodiments, and advantages of 
the present invention will become apparent from the fol-
lowing detailed description with reference to the drawings, 
wherein: 
[0032] FIG. 1 is a side cross-sectional schematic view of 
a breath condensate collection apparatus in accordance with 
a first preferred embodiment of the present invention; 
[0033] FIG. 2 is a right end cross-sectional view of the 
apparatus of FIG. 1, taken along line 2-2, showing the 
double-wall construction; 
[0034] FIG. 3 is a right end view of the apparatus of FIG. 
1; 
[0035] FIG. 4 is a side cross-sectional schematic view of 
the breath condensate collection apparatus of FIG. 1 with 
the plunger assembly in a fully depressed position; 
[0036] FIG. 5 is a side cross-sectional schematic view of 
a breath condensate collection apparatus in accordance with 
a second preferred embodiment of the present invention; 
[0037] FIG. 6A is a partial side view of the plunger 
assembly of FIG. 5, illustrating one type of protrusion; 
[0038] FIG. 6B is a right end view of the plunger assem-
bly of FIG. 6A; 
[0039] FIG. 7A is a partial side view of the plunger 
assembly of FIG. 5, illustrating another type of protrusion; 
[0040] FIG. 7B is a right end view of the plunger assem-
bly of FIG. 7A; 
[0041] FIG. 7C is a partial side cross-sectional view of the 
plunger assembly of FIG. 7A; 
[0042] FIG. 8 is a side cross-sectional schematic view of 
a breath condensate collection apparatus in accordance with 
a third preferred embodiment of the present invention; 
[0043] FIG. 9 is a side cross-sectional schematic view of 
the breath condensate collection apparatus of FIG. 1, shown 
in an inverted orientation; 
[0044] FIG. 10 is a side cross-sectional schematic view of 
a breath condensate collection apparatus in accordance with 
a fourth preferred embodiment of the present invention; 
[0045] FIG. 11 is a cross-sectional schematic view of a 
removable outlet cap for use with the apparatus of FIG. 10; 
[0046] FIG. 12 is a cross-sectional schematic view of a 
removable sampling well for use with the apparatus of FIG. 
10; and 
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[0047] FIG. 13 is a side cross-sectional schematic view of 
the breath condensate collection apparatus of FIG. 10 with 
the sampling well installed thereon. 
DETAILED DESCRIPTION OF IBE 
PREFERRED EMBODIMENTS 
[0048] Referring now to the drawings, in which like 
numerals represent like components throughout the several 
views, a variety of breath condensate collection apparatuses 
10 110 210 310 in accordance with the preferred embodi-m~nts ;f the 0pres~nt invention, is next shown and described. 
[0049] FIG. 1 is a side cross-sectional schematic view of 
a breath condensate collection apparatus 10 in accordance 
with a preferred embodiment of the present invention. The 
breath condensate collection apparatus 10 includes a double-
walled syringe 20 and a breath input assembly 50. The inner 
wall 22 of the syringe 20 defines a central cylinder 24 in 
which is fitted a plunger assembly 25 that includes a piston 
26, a rubber gasket 28 and a handle 30 extending from one 
end of the syringe 20. The outer wall 32 is arranged around 
the inner wall 22 in such a way as to create a narrow space 
between the inner and outer walls 22, 32. FIG. 2 is a right 
end cross-sectional view of the apparatus 10 ofFIG.1, taken 
along line 2-2, showing the double-wall construction, and 
FIG. 3 is a right end view of the apparatus 10 of FIG. 1. 
During manufacture, the space between the inner and outer 
walls 22, 32 may be filled with a jacket of coolant material 
34, and the outer wall 32 may then be sealed to the inner wall 
22 to prevent leakage. In a preferred embodiment, water 
may be used as the coolant material 34, but it should be clear 
that other materials may likewise be used, such as polyeth-
ylene glycol ("PEG") and the like. 
[0050] The syringe 20 further includes an inlet 36, an 
outlet 38, a collection port 39 and a pair of one-way valves 
40, 42. The first valve 40 is an intake valve that may be 
disposed in or adjacent to the inlet 36, while the second 
valve 42 is an exit valve that may be disposed in or adjacent 
to the outlet 38 in order to facilitate the passage of exhaled 
air through the central cylinder 24 in only a single direction. 
The outlet valve 42 is preferably disposed between the 
central cylinder 24 and the collection port 39 for purposes 
that will be made evident hereinbelow. The outlet 38 is 
preferably disposed at the end opposite the plunger handle 
30 in order to permit materials collected within the central 
cylinder 24 to be expressed through the outlet 38 by the 
piston 26. The valves 40, 42 are illustrated only schemati-
cally in the various drawings, but they may, for example, 
include two or three self-sealing leaves formed from plastic 
or another deformable polymer. The design of such valves 
would be apparent to those of ordinary skill in the art. 
[0051] Further, because the piston 26 fills one end of the 
syringe 20 and the outlet 38 is disposed in the opposite end, 
the inlet 36 is preferably arranged to penetrate both the inner 
and outer walls 22, 32 on the side of the syringe 20. In order 
to cause the most interaction between exhaled air passing 
through the central cylinder 24 and the inner surfaces 44 of 
the inner wall 22, the inlet 36 is preferably disposed as close 
to the piston 26 as possible; however, it will be clear that 
other arrangements of these components are likewise pos-
sible without departing from the scope of the present inven-
tion. 
[0052] The breath input assembly 50 includes a mouth-
piece 52, a filter 54 and any tubing 56 necessary to guide 
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exhaled breath from the mouthpiece 52 to the inlet 36 of the 
syringe 20. The mouthpiece 52 is of suitable size and shape 
so as to permit comfortable contact with the mouth area of 
a patient. The filter 54, which may comprise a polymer 
material having perforations or successive intrusions 
therein, may be arranged within the tubing 56 between the 
mouthpiece 52 and the syringe inlet 36 to prevent saliva and 
other liquid or solid matter of a minimum size from passing 
therethrough and into the syringe 20. Saliva may be further 
prevented from reaching the central cylinder 24 by arranging 
the breath input assembly 50 beneath the syringe 20, so that 
air passing through the breath input assembly 50 moves 
upward. In this arrangement, the effect of gravity on the 
saliva and other liquid or solid matter helps to prevent such 
matter from passing up into the central chamber 24, as it 
instead tends to collect in the tubing 56. 
[0053] The tubing 56 is preferably configured so as to 
avoid interference between the mouthpiece 52, or any other 
part of the tubing 56, and the operation of the plunger 
assembly 25, as such operation is described herein. More 
preferably, the mouthpiece 52 is oriented to be generally 
parallel with the syringe 20 and the plunger assembly 25 
therein, or in other words, the mouthpiece 52 is oriented in 
parallel to the main axis defined by the syringe 20. In this 
orientation, exhaled breath may be received from a patient 
without causing interference to the operation of the plunger 
assembly 25, and condensate formed on the inside of the 
syringe 20 as the patient uses the apparatus 10 will tend to 
drain downward toward the outlet 38. 
[0054] The dimensions of the apparatus 10 are chosen so 
that a sufficient volume of condensate may be collected in a 
relatively short period of time using an apparatus 10 that is 
small and light enough to be easily held by a patient or 
attendant and that does not require the patient to change his 
breathing patterns. The walls 22, 32 and other structures of 
the apparatus 10 are preferably constructed of a material that 
tends not to bind to proteins, such as platinum-cured silicon, 
but other suitable materials may include, but are not limited 
to, glass, plastic, polyethylene, polycarbonate, or polyvinyl 
or other synthetic polymer. The plunger assembly 25 may is 
likewise preferably constructed from a non-protein-binding 
material, but may be constructed from any suitable inert 
material including, but not limited to, plastic, vinyl, poly-
ethylene, rubber, platinum-cured silicon or TEFLON®. In a 
preferred embodiment, the syringe 20 is between 10 and 20 
cm long with a diameter of between 2 and 5 cm, and the 
collection port 39 is between 5 and 20 mm long with an 
internal diameter of between 3 and 10 mm. The thickness of 
the coolant jacket 34 may be between 1 and 10 mm, and the 
sample volume, expressed from a single use, is preferably 
between 100 µL and 1000 µL, although it may be possible 
to obtain useful results from samples as small as 25 µL. 
[0055] In operation, one or more syringes 20 are first 
stored in a refrigeration device, such as a conventional 
household or commercial freezer, that is capable of lowering 
the temperature to approximately 0° F., thus freezing the 
jacket of coolant material 34 contained between the inner 
and outer walls 22, 32 of the syringe 20. When a patient is 
to be examined, a single syringe 20 is first withdrawn from 
the freezer. If the breath input assembly 50 or mouthpiece 52 
is stored separately from the rest of the apparatus 10, then 
the apparatus 10 is assembled for use by coupling the 
various components together. Next, the patient positions the 
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mouthpiece 52 in a sealed relationship to his mouth area and 
exhales into the mouthpiece 52. The exhaled breath is 
guided through the tubing 56 and into the central cylinder 24 
via the inlet 36. The intake valve 40 is forced open by 
positive pressure, but in the absence of such pressure it 
prevents air within the central cylinder 24 from escaping 
through the inlet 36. The exhaled breath then exits through 
the outlet 38 on the end of the cylinder 24 opposite the intake 
end. The exit valve 42 permits air to pass out of the central 
cylinder 24 only when positive pressure exists on the 
cylinder side of the valve 42, while in the absence of such 
pressure the valve 42 prevents ambient air from entering the 
central cylinder 24 via the outlet 38. 
[0056] As the patient exhales through the apparatus 10, the 
moisture in the exhaled breath begins to condense on the 
inner surfaces 44 of the central cylinder 24. Because of the 
depressed temperature of the coolant 34 and the syringe 20, 
the condensate may freeze immediately on the inner surface 
44. The collection port 39 is preferably nipple-shaped and 
approximately 1 cm long with a diameter small enough to 
cause some minimal resistance to the exhalation of the 
patient. The diameter is preferably chosen so as to slow the 
rate of expiration such that each exhalation requires approxi-
mately 5 seconds to complete. This increases the amount of 
time for exhaled breath to equilibrate with the inside sur-
faces 44 of the central cylinder 24. 
[0057] As the patient continues to exhale through the 
apparatus 10, the frozen coolant 34 begins to melt. The 
composition, volume and thickness of the coolant jacket 34 
surrounding the internal cylinder 24 is preferably calibrated 
such that the coolant 34 begins to melt after approximately 
10-15 exhalations by the patient. Once the material 34 melts 
or thaws after the desired number of exhalations, the con-
densate likewise can begin to melt. Once the condensate is 
melted, the plunger assembly 25 may be depressed to 
express the collected condensate sample through the outlet 
38 and into the collection port 39. FIG. 4 is a side cross-
sectional schematic view of the breath condensate collection 
apparatus 10 of FIG. 1 with the plunger assembly 25 in a 
fully depressed position. The location of the exit valve 42 in 
the outlet 38 between the central cylinder 24 and the 
collection port 39 then permits the collected condensate to 
be aspirated from the collection port 39 using a conventional 
pipette (not shown). The condensate may then be transferred 
from the pipette to a separate assay well for analysis thereof 
as desired. Finally, once the condensate has been collected 
and withdrawn from the collection port 39, the entire appa-
ratus 10 may be disposed of according to conventional waste 
disposition procedures. 
[0058] Although not required, the plunger assembly 25 of 
the breath condensate collection apparatus 10 may further 
include one or more clips 31 disposed around the end of the 
syringe 20 opposite the collection port 39. These clips 31 are 
preferably formed from a resilient material and are designed 
to be deformed away from the syringe 20 as the plunger 
handle 30 is forced therebetween. The clips 31 are then 
biased back into place by their natural resiliency once the 
handle 30 is completely depressed into the syringe 20 as 
shown in FIG. 4. Once in this position, the plunger assembly 
25 is effectively and conveniently locked in place by the 
clips 31, thereby permitting the syringe 20 to be transported 
and handled much more safely and reliably. It should be 
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apparent, however, that such clips 31 are not necessary in 
order to be able to practice the various embodiments of the 
present invention. 
[0059] FIG. 5 is a side cross-sectional schematic view of 
a breath condensate collection apparatus 110 in accordance 
with a second preferred embodiment of the present inven-
tion. This apparatus 110 may be identical to the apparatus 10 
of the first preferred embodiment, except that a semi-conical 
protrusion 127 (shown schematically in FIG. 5) is disposed 
on the surface of the piston 26 facing the outlet 38, the 
collection port 139 is sized and shaped to matingly receive 
the protrusion 127 therein, and the exit valve 42 is located 
at the distal end of the collection port 139. The collection 
port 139 may then be connected to a colorimetric device 
designed to detect condensate analytes. 
[0060] Notably, although the exit valve 42 and protrusion 
127 are shown only schematically in the drawings, the exit 
valve 42 is preferably positioned as close to the end of the 
collection port 139 as possible, and the protrusion 127 is 
preferably sized and shaped so as to abut the valve 42 when 
the plunger assembly 25 is fully depressed into the central 
cylinder 24. This design minimizes the amount of fluid that 
will remain in the syringe 20 when the plunger assembly 25 
is fully depressed, and thus minimizes the amount of con-
densate that is available for subsequent testing. 
[0061] FIGS. 6A and 6B are a partial side view and a right 
end view, respectively, of the plunger assembly 25 of FIG. 
5, illustrating one type of protrusion 127. This type of 
protrusion 127 includes a series of grooves 129 arranged in 
the surface thereof and extending from the base of the 
protrusion 127 to the tip. As the piston 26 is pushed into the 
very end of the central cylinder 24, the grooves 129 serve as 
conduits for the condensate remaining in the syringe 20, thus 
permitting a small amount of additional condensate to be 
collected via the collection port 139 rather than be trapped 
in the end of the central cylinder 24. This effect could be 
further enhanced by the inclusion of additional groove 
structures (not shown) in the fiat surface of the piston 26 that 
could be used to guide condensate to the grooves 129 in the 
protrusion 127. 
[0062] FIGS. 7 A, 7B and 7C are a partial side view, a right 
end view and a partial side cross-sectional view, respec-
tively, of the plunger assembly 25 of FIG. 5, illustrating 
another type of protrusion 127. This type of protrusion 127 
includes a plurality of openings 231 arranged around the 
base of the protrusion 127 and connecting to a hollow shaft 
233 that exits through the tip of the protrusion 127. The 
openings 231 and central shaft 233 may be between 1 and 2 
mm in diameter. Once again, as the piston 26 is pushed into 
the very end of the central cylinder 24, the openings 231 and 
hollow shaft 233 serve as conduits for the condensate 
remaining in the syringe 20, thus permitting a small amount 
of additional condensate to be collected via the collection 
port 139 rather than be trapped in the end of the central 
cylinder 24. This effect could also be further enhanced by the 
inclusion of additional groove structures (not shown) in the 
fiat surface of the piston 26 that could be used to guide 
condensate to the openings 231 in the protrusion 127. The 
central shaft 233 could also be fitted with a rigid but hollow 
tube structure (not shown) of between 1 and 2 mm (external 
diameter) to provide a needle-like extension through which 
the fluid sample could be directed and extruded when the 
plunger assembly 25 is fully depressed. 
US 2004/0138577 Al 
[0063] FIG. 8 is a side cross-sectional schematic view of 
a breath condensate collection apparatus 210 in accordance 
with a third preferred embodiment of the present invention. 
Like the apparatuses of the first and second embodiments 10, 
110, this breath condensate collection apparatus 210 
includes a syringe 220, having inner and outer walls 222, 
232, and a breath input assembly 50. The syringe 220 and 
the breath input assembly 50 are generally similar to those 
of the first embodiment. However, unlike the first embodi-
ment, the outlet 238 and the outlet valve 42 are disposed on 
the top of the syringe 220, near the end opposite the plunger 
handle 30, and the syringe 220 further includes a collection 
port 239, disposed on the bottom of the syringe 220 at the 
very end of the central cylinder 224, and a cap 37 for 
covering the collection port 239. The cap may be threaded 
or otherwise adapted for secure connection of the cap 37 to 
the collection port 239 in order to temporarily close the 
collection port 239. This apparatus 210 functions the same 
way as the first apparatus embodiment 10 except that 
exhaled breath exits through the outlet 238 on the top of the 
syringe 220, but condensate may be collected and expressed 
from the central cylinder 224 via the collection port 239 on 
the bottom of the syringe 220. The cap 37 prevents exhaled 
air from passing through the collection port 239, but may be 
unscrewed or otherwise removed when it is desired to 
collection the condensate from the central cylinder 224. This 
may be particularly useful, for example, in expressing 
condensate directly into an analyzer temporarily or perma-
nently mounted on or adjacent the syringe 220, as described 
in co-pending and commonly-assigned U.S. Provisional 
Patent Application No. 60/447,581, filed Feb. 14, 2003. 
[0064] As described previously, it is advantageous for the 
breath input assembly 50 in each of the three embodiments 
10, 110, 210 discussed thus far to be arranged beneath the 
respective syringe 20, 220 in order to aid in preventing 
saliva and other matter from reaching the central cylinder or 
chamber 24, 224. However, it will be apparent that the 
breath input assembly 50 may instead be oriented such that 
the breath input assembly 50 is located at the top of the 
syringe 20, 220. FIG. 9 is a side cross-sectional schematic 
view of the breath condensate collection apparatus 10 of 
FIG. 1, shown in an inverted orientation, whereby the breath 
input assembly 50 is disposed at the top of the syringe 20. 
Although saliva may be more likely to enter the syringe 20, 
it should be apparent that other features of the present 
invention may not be affected by this arrangement. Although 
not shown, the apparatuses 110, 210 of the second and third 
embodiments may likewise be rearranged, although it 
should be noted that the breath input assembly 50 in the third 
apparatus 210 would have to be placed on the opposite side 
of the collection port 239 in order to facilitate proper 
operation thereof. 
[0065] FIG. 10 is a side cross-sectional schematic view of 
a breath condensate collection apparatus 310 in accordance 
with a fourth preferred embodiment of the present invention. 
Like the apparatus 10 of the first embodiment, this breath 
condensate collection apparatus 310 includes a double-
walled syringe 320 and a breath input assembly 350. The 
inner wall 322 of the syringe 320 defines a central chamber 
324, but unlike the central cylinder 24 of the first embodi-
ment, the central chamber 324 of the alternative embodi-
ment need not be cylindrical. The outer wall 332 is arranged 
around the inner wall 322 in such a way as to create a narrow 
space between the inner and outer walls 322, 332. Like the 
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apparatus 10 of the first embodiment, however, the space 
between the inner and outer walls 322, 332 may be filled 
during manufacture with a jacket of coolant material 34, and 
the outer wall 332 is then sealed to the inner wall 322 to 
prevent leakage. 
[0066] The syringe 320 further includes an inlet 36, an 
outlet cap 60 and a first one-way valve 40. The first valve 40 
is an intake valve that may be disposed in or adjacent to the 
inlet 36. FIG. 11 is a cross-sectional schematic view of a 
removable outlet cap 60 for use with the apparatus of FIG. 
10. The outlet cap 60 includes an outlet 338 and a second 
valve 342, which is an exit valve disposed in or adjacent to 
the outlet 338 in order to facilitate the passage of exhaled air 
through the central chamber 324 in only a single direction. 
The outlet cap 60 is preferably disposed at the end of the 
central chamber 324 opposite the inlet 36. 
[0067] The breath input assembly 350 includes a mouth-
piece 52, a filter 54 and any tubing 356 necessary to guide 
exhaled breath from the mouthpiece 52 to the inlet 36 of the 
syringe 320. As with the first embodiment of the apparatus 
10, the mouthpiece 52 is of suitable size and shape so as to 
permit comfortable contact with the mouth area of a patient, 
and the filter 54 may be arranged within the tubing 356 
between the mouthpiece 52 and the syringe inlet 36 to 
prevent saliva and other liquid or solid matter of a minimum 
size from passing therethrough and into the syringe 320. 
[0068] Unlike the embodiments described previously, the 
apparatus 310 of the fourth embodiment does not include a 
plunger assembly. Instead, as illustrated in FIG. 10, one or 
more obstructive internal structures 62 may be arranged 
inside the central chamber 324 in order to increase the 
surface area with which exhaled breath that passes through 
the central chamber 324 may come in contact. Suitable 
obstructive structures 62 may include grid-like structures 
and other baffles, spheres such as those shown in FIG. 10, 
or other geometric shapes formed from metal, glass, or other 
suitable materials. These structures 62 may be held in place 
within the syringe 320 using appropriate screens, bosses or 
the like (not shown). If cooled in like manner to the syringe 
20 of the first embodiment, breath condensate may subse-
quently be produced inside the central chamber 324 more 
efficiently. 
[0069] However, because the obstructive structures 62 
occupy the interior of the central chamber 324, removal of 
the condensate collected thereon may require flushing the 
interior of the central chamber 324 with a suitable buffer 
solution 72 of known volume and composition. For 
example, the solution may consist of distilled water, or water 
containing an organic dye to indicate the pH of the solution 
using visual or spectrophotometric colorimetry. In a pre-
ferred method of operation of the alternative embodiment 
shown in FIG. 10, the apparatus 310 is oriented horizontally 
(not shown), and breath condensate is collected on the inner 
surfaces 44 of the central chamber 324 and on the obstruc-
tive structures 62 in the same manner as described with 
respect to the first embodiment. The apparatus 310 may then 
be rotated to the vertical orientation shown in FIG. 10. With 
the apparatus 310 in the illustrated orientation, the outlet cap 
60 may be removed without danger of the condensate inside 
the syringe 320 escaping. Suitable connection means, such 
as corresponding screw threads or the like, are preferably 
provided on the syringe 320 and the outlet cap 60 to 
facilitate such removal. 
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[0070] Once the outlet cap 60 has been removed, the 
buffer solution 72 may be added to the central chamber 324 
in order to wash the collected condensate therefrom. Suit-
able buffer solutions and volumes will be apparent to those 
of ordinary skill of the art. FIG. 12 is a cross-sectional 
schematic view of a removable sampling well 70 for use 
with the apparatus of FIG. 10. With the outlet cap 60 
removed and the apparatus oriented as shown in FIG. 10, a 
sampling well 70 such as that shown in FIG. 12 may be 
fastened onto the open end of the syringe 320 to close that 
end. FIG. 13 is a side cross-sectional schematic view of the 
breath condensate collection apparatus 310 of FIG. 10 with 
the sampling well 70 installed thereon. Once the sampling 
well 70 is in place, the entire apparatus 310 may be inverted 
to the orientation shown in FIG. 13, thus causing the buffer 
solution 72 to wash the collected breath condensate out the 
bottom of the syringe 320 and into the sampling well 70. 
Once collected in the sampling well 70, the sampling well 70 
may once again be removed and the buffered condensate 74 
may be aliquotted for testing as desired. 
[0071] In a variation of the various embodiments 
described herein, any of the syringes 10, 110, 210, 310 may 
alternatively be cooled via an endothermic reaction, such as 
that created when NH4 N03 is hydrated with water in a 1:4 
molar ratio, to produce a temperature below 0° C. for 
approximately 10 minutes. This may be facilitated by storing 
water in the space between the walls of the syringe 10, 110, 
210, 310 in breakable ampules, surrounded by dry NH4N03 , 
or by sealing only the NH4 N03 in the same space, to be 
hydrated or otherwise injected with water via a needle port. 
NH4 N03 may be prepared because the reaction may be 
triggered by injecting the NH4N03 material with a preset 
volume of tap water or saline via the needle port, similar to 
the way a nurse would "flush" an IV line, but it should be 
apparent that other materials may likewise be used to create 
a suitable endothermic reaction. For example, a commercial 
gel refrigerant that may be activated by slight compression 
of the outer wall of the syringe may likewise be used. One 
such material is Cold Ice, produced by Cold Ice, Inc. of 
Oakland, Calif. 
[0072] Once the sample is obtained using any of the 
various apparatuses 10, 110, 210, 310 described herein, or 
by some alternative means, a battery of tests may be 
performed on the sample in order to detect lung ischemia. 
The battery of tests may include measuring or testing for 
fibrinopeptides, thromboxane B2, platelet activating factor, 
leukotrienes C, D and E, carbon monoxide-to-nitric oxide 
ratio and chemokine and other proteins. Each of these has 
specific purposes, as described below. The various tests may 
all be performed in a manner well known to those of 
ordinary skill in the art. 
[0073] Measurement of fibrinopeptides in breath conden-
sate is believed to have the potential to allow more localized 
measurement of the presence of clot in the lung vasulature. 
As described previously, thrombin cleaves fibrinogen A 
peptide from fibrinogen as a prerequisite to fibrin gelation. 
Owing to its small size, it is hypothesized that fibrinopep-
tides will traverse the alveolar membrane, and equilibrate in 
alveolar fluid, and thus will be found in exhaled condensate. 
Thus, the presence of fibrinopeptides in the breath conden-
sate sample would indicate the presence of clot. 
[0074] Also, pulmonary vascular constriction may be 
detected by measuring PGF2 ., thromboxane B2 , PAF, leu-
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kotrienes C, D, and E, and the ratio of CO:NO in condensate, 
thus providing a basis for initiating pulmonary vasodilator 
therapy or COXl,2 inhibition. Our laboratory has used an 
experimental pulmonary vascular occlusion (PYO), induced 
by venous infusion of polystyrene microspheres in a rat, to 
determine three major findings related to breath condensate 
analysis. We and others have found increased content of 
PGF2 w thromboxane B2 , platelet activating factor (PAF) 
and vasoconstrictive leukotrienes C, D, and E in the lung 
washings in our rat model. (Nakos, Am J Resp Crit Care 
Med 1998, 158:1504) The magnitude of the concentration of 
these vasoconstrictive agents correlated with the severity of 
hypoxemia and pulmonary hypertension. We also have 
found extremely elevated expression of the gene encoding 
heme oxygenase-1 but the nearly complete absence of 
expression of the gene encoding for the inducible enzyme, 
nitric oxide synthase. Heme oxygenase produces carbon 
monoxide (CO) from heme substrate whereas nitric oxide 
synthase produces nitric oxide (NO). Both are vasodilator 
substances. In rats subjected to PYO, we have also found 
early increases in lung gene expression of cytokine induced 
neutrophil attractant 1 and 2 (CINC 1 & 2), and monocyte/ 
macrophage chemoattractant protein (MCP) 1 and 2, and 
monocyte/macrophage inflammatory proteins (MIP) la and 
l~ with concomitant increases in each protein in the wash-
ings from the lung airways and alveoli obtained as soon as 
2 hours after induction of PE, and lasting up to 18 hours after 
PE induction. The chemoattractant molecules can cause the 
migration of leukocytes into the affected area, and through 
this mechanism, can potentiate injury during therapeutic 
reperfision. 
[0075] Further, the presence of certain chemokines in 
exhaled condensate is believed to predispose reperfusion 
injury. The chemokines discovered in rats included CINC 1, 
CINC 2, MIP la, MIP l~, and MCP 1 and 2. The human 
homologues that will be tested in our device will include 
CXCLl, CXCL 2 and CXCL 3; CCL 2, CCL 3, CCL 4 and 
CCL8, using nomenclature outlined by Zlotnick and Yoshie, 
Immunity, 2000; 12:121-127. Investigators have found 
chemokines with an inflammatory model of pulmonary 
hypertension. (Kimura, Lab Invest 1998-78:571-81; Ikeda, 
Am J Physiol Heart Circ Physiol, 2002, 283(5):H2021-8). 
Unlike the in-vivo PYO model, which causes primarily 
obstructed blood flow, the model in the latter study incites 
inflammation and remodeling, which over weeks leads to 
vascular occlusion. Likewise, investigators have also found 
increased chemokine expression in lungs subjected to hilar 
ligation or clamping, which interrupts both perfusion and 
ventilation. The latter model differs significantly from in-
vivo PYO because alveolar ventilation continues with in-
vivo PYO. Thus the ischemic insult differs with in-vivo 
PYO versus hilar ligation. 
[0076] Based on the foregoing information, it is readily 
understood by those persons skilled in the art that the present 
invention is susceptible of broad utility and application. 
Many embodiments and adaptations of the present invention 
other than those specifically described herein, as well as 
many variations, modifications, and equivalent arrange-
ments, will be apparent from or reasonably suggested by the 
present invention and the foregoing descriptions thereof, 
without departing from the substance or scope of the present 
invention. Accordingly, while the present invention has been 
described herein in detail in relation to its preferred embodi-
ment, it is to be understood that this disclosure is only 
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illustrative and exemplary of the present invention and is 
made merely for the purpose of providing a full and enabling 
disclosure of the invention. The foregoing disclosure is not 
intended to be construed to limit the present invention or 
otherwise exclude any such other embodiments, adaptations, 
variations, modifications or equivalent arrangements; the 
present invention being limited only by the claims appended 
hereto and the equivalents thereof. Although specific terms 
are employed herein, they are used in a generic and descrip-
tive sense only and not for the purpose of limitation. 
What is claimed is: 
1. A breath condensate collection apparatus comprising: 
a central chamber having double side walls and first and 
second opposing ends, wherein the double side walls 
include an inner side wall and an outer side wall in 
spaced relationship to one another; 
a coolant material sealed between the inner and outer side 
walls for cooling at least the inner walls of the central 
chamber; 
a breath input assembly disposed on the outside of the 
outer side wall of the central chamber and penetrating 
both the inner and outer side walls such that the interior 
of the breath input assembly is in fluid communication 
with the interior of the central chamber; 
a plunger assembly having a piston and a handle, wherein 
the piston is slidably disposed in the interior of the 
central chamber in snug contact with the inner side wall 
and wherein the handle extends from the first end of the 
central chamber so as to permit the piston to be moved 
within the central chamber; and 
a breath condensate collection port, disposed at the sec-
ond end of the central chamber, in fluid communication 
with the interior of the central chamber. 
2. The breath condensate collection apparatus of claim 1, 
wherein the plunger assembly is adjustable between a fully 
retracted position and a fully depressed position, and 
wherein when the plunger is in its fully retracted position, 
the fluid connection between the breath input assembly and 
the central chamber lies in between the piston and the second 
end of the central chamber. 
3. The breath condensate collection apparatus of claim 2, 
wherein the location of the breath input assembly on the 
outside of the outer side wall of the central chamber is 
adjacent the first end of the central chamber. 
4. The breath condensate collection apparatus of claim 3, 
wherein the location of the breath input assembly is under-
neath the central chamber. 
5. The breath condensate collection apparatus of claim 3, 
wherein the central chamber includes an end wall at the 
second end thereof, and wherein the breath condensate 
collection port is disposed in the end wall of the central 
chamber. 
6. The breath condensate collection apparatus of claim 5, 
wherein the piston includes a surface facing toward the 
second end of the central chamber, wherein a protrusion is 
disposed on the surface of the piston, and wherein the 
protrusion is adapted to fit into the breath condensate 
collection port when the plunger assembly is fully depressed 
into the central chamber. 
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7. The breath condensate collection apparatus of claim 6, 
wherein the breath condensate collection port and the pro-
trusion are each semi-conical in shape. 
8. The breath condensate collection apparatus of claim 6, 
wherein one or more grooves are disposed in the sides of the 
protrusion to facilitate guiding breath condensate toward the 
breath condensate collection port. 
9. The breath condensate collection apparatus of claim 6, 
wherein one or more internal passages are disposed in the 
interior of the protrusion to facilitate guiding breath con-
densate toward the breath condensate collection port. 
10. The breath condensate collection apparatus of claim 9, 
further comprising a rigid, hollow tube structure extending 
from one of the internal passages through which fluid from 
the interior of the protrusion may be directed. 
11. The breath condensate collection apparatus of claim 2, 
wherein the breath condensate collection port is disposed on 
the outside of the outer side wall of the central chamber 
adjacent the second end thereof. 
12. The breath condensate collection apparatus of claim 
11, wherein the breath condensate collection port is disposed 
on the bottom of the central chamber, the breath condensate 
collection apparatus further comprising an outlet and an 
outlet valve disposed on the top of the outer side wall of the 
central chamber adjacent the second end thereof. 
13. The breath condensate collection apparatus of claim 
12, further comprising a cap for temporarily sealing the 
breath condensate collection port. 
14. The breath condensate collection apparatus of claim 2, 
wherein the breath condensate collection apparatus defines a 
main axis, wherein the breath input assembly includes a 
mouthpiece and a tube structure connecting the mouthpiece 
to the side of the central chamber, and wherein the mouth-
piece is generally oriented in parallel to the main axis of the 
breath condensate collection apparatus. 
15. The breath condensate collection apparatus of claim 2, 
further comprising at least one clip, mounted at the first end 
of the central chamber, for locking the handle of the plunger 
assembly in a fully depressed position to facilitate transport 
or handling of the breath condensate collection apparatus 
until breath condensate collected therein may be removed. 
16. A method of collecting breath condensate, the method 
comprising: 
providing a central chamber having double side walls, 
first and second opposing ends, a coolant material 
sealed between the inner and outer side walls for 
cooling at least the inner walls of the central chamber, 
and a breath condensate collection port disposed at the 
second end of the central chamber; 
lowering the temperature of the coolant material to chill 
at least the inner walls of the central chamber; 
receiving, in the interior of the central chamber, exhaled 
breath from a patient, delivered through the inner and 
outer side walls via a breath input assembly disposed 
on the outside of the outer side wall of the central 
chamber; 
condensing portions of the exhaled breath on the inner 
surfaces of the inner walls of the central chamber; 
expressing condensate, produced during the condensing 
step, from the central chamber by depressing a plunger 
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assembly through the central chamber, thereby forcing 
the condensate into the breath condensate collection 
port; and 
aspirating the expressed condensate from the breath con-
densate collection port for analysis thereof. 
17. The method of claim 16, wherein the aspirating step 
includes aspirating the expressed condensate into a pipette, 
the method further comprising: 
transferring the condensate from the pipette to a separate 
assay well for analysis thereof. 
18. The method of claim 17, wherein providing a central 
chamber includes providing a central chamber having an 
outlet and outlet valve disposed on the top of the outer side 
wall of the central chamber adjacent the second end thereof 
and the breath condensate collection port disposed on the 
bottom of the central chamber, the method further compris-
ing: 
temporarily sealing the breath condensate collection port 
during the receiving and condensing steps. 
19. The method of claim 17, wherein providing a central 
chamber includes providing a central chamber having at 
least one clip mounted at the first end of the central chamber, 
the method further comprising: 
after expressing the condensate by depressing the plunger 
assembly, locking, via the at least one clip, the handle 
of the plunger assembly in a fully depressed position to 
facilitate transport or handling of the breath condensate 
collection apparatus until aspirating the expressed con-
densate. 
20. The method of claim 17, wherein receiving exhaled 
breath includes receiving the exhaled breath delivered 
through the inner and outer side walls via a breath input 
assembly disposed underneath the central chamber. 
21. A breath condensate collection apparatus comprising: 
a central chamber having double side walls including an 
inner side wall and an outer side wall in spaced 
relationship to one another; 
a coolant material sealed between the inner and outer side 
walls for cooling at least the inner walls of the central 
chamber; 
a breath input assembly, the interior of which is in fluid 
communication with the interior of the central cham-
ber; 
one or more obstructive structures arranged in the interior 
of the central chamber for increasing the surface area 
on which condensate may form; and 
a breath condensate collection port in fluid communica-
tion with the interior of the central chamber. 
22. The breath condensate collection apparatus of claim 
21, wherein the obstructive structures include grid-like 
structures. 
23. The breath condensate collection apparatus of claim 
21, wherein the obstructive structures include discrete geo-
metric structures. 
24. The breath condensate collection apparatus of claim 
23, wherein the discrete geometric structures include spheri-
cal objects. 
25. The breath condensate collection apparatus of claim 
23, wherein the discrete geometric structures are formed 
from metal. 
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26. The breath condensate collection apparatus of claim 
23, wherein the discrete geometric structures are formed 
from glass. 
27. The breath condensate collection apparatus of claim 
21, wherein the obstructive structures are fixed in place 
within the interior of the central chamber. 
28. The breath condensate collection apparatus of claim 
21, wherein the obstructive structures are free-floating 
within the interior of the central chamber. 
29. The breath condensate collection apparatus of claim 
28, wherein movement of the obstructive structures is 
restricted to a particular portion of the central chamber. 
30. The breath condensate collection apparatus of claim 
21, wherein the location of the breath input assembly is 
underneath the central chamber. 
31. A method of collecting breath condensate, the method 
comprising: 
providing a double-walled central chamber having one or 
more obstructive structures arranged in the interior 
thereof and a coolant material sealed between the inner 
and outer side walls for cooling at least the inner walls 
of the central chamber; 
lowering the temperature of the coolant material to chill 
at least the inner walls of the central chamber and the 
obstructive structures; 
receiving, in the interior of the central chamber, exhaled 
breath from a patient; 
condensing portions of the exhaled breath on the inner 
surfaces of the inner walls of the central chamber and 
on the obstructive structures; and 
removing condensate, produced during the condensing 
step, from the central chamber. 
32. The method of claim 31, wherein the removing step 
includes washing the condensate from the obstructive struc-
tures. 
33. The method of claim 32, wherein the washing step 
includes adding an amount of liquid to the central chamber, 
wherein the amount is selected to correspond to the amount 
of condensate present in the central chamber. 
34. The method of claim 32, wherein the washing step 
includes adding an amount of liquid to the central chamber, 
wherein the amount is selected to correspond to the amount 
of condensate likely to be present in the central chamber 
after the patient exhales into the central chamber for a 
predetermined period of time. 
35. The method of claim 32, wherein the washing step 
includes adding an amount of liquid to the central chamber, 
wherein the amount is selected to correspond to the amount 
of condensate likely to be present in the central chamber 
after the patient completes a predetermined number of 
exhalations into the central chamber. 
36. The method of claim 32, further comprising the step 
of removing the obstructive structures from the central 
chamber before carrying out the washing step. 
37. A method of collecting breath condensate, the method 
comprising: 
providing a double-walled central chamber having a 
removable outlet assembly and a coolant material 
sealed between the inner and outer side walls for 
cooling at least the inner walls of the central chamber; 
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lowering the temperature of the coolant material to chill 
at least the inner walls of the central chamber; 
receiving, in the interior of the central chamber, exhaled 
breath from a patient; 
condensing portions of the exhaled breath on the inner 
surfaces of the inner walls of the central chamber; 
removing the outlet assembly and replacing it with a 
sampling well; and 
moving condensate, produced during the condensing step, 
from the central chamber to the sampling well. 
38. The method of claim 37, wherein the step of moving 
condensate includes washing condensate from the central 
chamber into the sampling well with a known liquid. 
39. The method of claim 38, wherein the step of washing 
condensate includes: 
introducing a predetermined quantity of the known liquid 
into the central chamber; 
mixing the predetermined quantity of the known liquid 
with the condensate; and 
draining the known liquid and the condensate from the 
central chamber into the sampling well. 
40. The method of claim 39, wherein the step of removing 
the outlet assembly includes creating an opening into the 
central chamber, and wherein the step of introducing 
includes introducing the known liquid through the opening. 
41. The method of claim 39, further comprising: 
before replacing the outlet assembly with the sampling 
well, storing the known liquid in the sampling well. 
42. The method of claim 38, wherein the known liquid is 
a buffer solution. 
43. The method of claim 42, wherein the buffer solution 
is distilled water. 
44. The method of claim 42, wherein the buffer solution 
includes an organic dye to indicate the pH of the solution. 
45. The method of claim 38, further comprising: 
before replacing the outlet assembly with the sampling 
well, storing the known liquid in the sampling well. 
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46. The method of claim 38, further comprising: 
before replacing the outlet assembly with the sampling 
well, storing the known liquid in the sampling well. 
47. A method of collecting breath condensate, the method 
comprising: 
providing a double-walled central chamber having one or 
more obstructive structures arranged in the interior 
thereof and a coolant material sealed between the inner 
and outer side walls for cooling at least the inner walls 
of the central chamber; 
calibrating the walls and coolant material of the double-
walled central chamber such that, when beginning at a 
predetermined temperature, a chosen number of 
breaths, received from a typical patient, creates a 
sufficient amount of breath condensate to be collected 
on the inner surfaces of the inner walls of the central 
chamber; 
lowering the temperature of the coolant material to the 
predetermined temperature to chill at least the inner 
walls of the central chamber; 
receiving, in the interior of the central chamber, a plurality 
of exhalations from a particular patient, wherein the 
number of exhalations is within a predetermined range 
established on the basis of the chosen number of 
breaths; 
condensing portions of the exhalations, received from the 
patient, on the inner surfaces of the inner walls of the 
central chamber; and 
removing condensate, produced during the condensing 
step, from the central chamber. 
48. The method of claim 47, wherein the predetermined 
range is 10 to 25 breaths, inclusive. 
49. The method of claim 47, wherein the predetermined 
temperature is the temperature of a standard freezer. 
50. The method of claim 49, wherein the predetermined 
temperature is 0° F. 
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